Patchy access to weight-loss jabs risks widening health inequalities, particularly between people who can and cannot afford private prescriptions for the drugs, medics have warned.
The likes of Mounjaro and Wegovy have been hailed as wonder drugs but there are also concerns that demand for the medications are fuelling a two-tier system.
The strict NHS rules on who is eligible, combined with a “slow” national rollout due to cost, means people are increasingly turning to private doctors – if they can afford it.
A monthly private prescription can cost patients between £100 and £250, and the drugs are most effective when taken long term.
Shorts
